• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Aldosterone 'escape' vs 'breakthrough'.

作者信息

Schrier Robert W

出版信息

Nat Rev Nephrol. 2010 Feb;6(2):61. doi: 10.1038/nrneph.2009.228.

DOI:10.1038/nrneph.2009.228
PMID:20111044
Abstract
摘要

相似文献

1
Aldosterone 'escape' vs 'breakthrough'.醛固酮“逃逸”与“突破”
Nat Rev Nephrol. 2010 Feb;6(2):61. doi: 10.1038/nrneph.2009.228.
2
The incidence and implications of aldosterone breakthrough.醛固酮突破的发生率及影响
Nat Clin Pract Nephrol. 2007 Sep;3(9):486-92. doi: 10.1038/ncpneph0575.
3
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?肾素-血管紧张素-醛固酮系统阻断中的血管紧张素II再激活和醛固酮逃逸现象：口服肾素抑制是解决办法吗？
Expert Opin Pharmacother. 2007 Apr;8(5):529-35. doi: 10.1517/14656566.8.5.529.
4
Kidney and adrenocortical hormones.肾脏和肾上腺皮质激素。
Nephron. 1975;15(3-5):261-78. doi: 10.1159/000180516.
5
Review of aldosterone- and angiotensin II-induced target organ damage and prevention.醛固酮和血管紧张素II诱导的靶器官损伤及预防的综述
Cardiovasc Res. 2004 Mar 1;61(4):663-70. doi: 10.1016/j.cardiores.2003.11.037.
6
Non-genomic effects of aldosterone: new actions and questions.
Trends Endocrinol Metab. 2004 Oct;15(8):353-4. doi: 10.1016/j.tem.2004.08.002.
7
Aldosterone and the kidney: a rapidly moving frontier (an update).醛固酮与肾脏：快速发展的前沿领域（更新版）。
Nephrol Dial Transplant. 2014 Nov;29(11):2012-9. doi: 10.1093/ndt/gft035. Epub 2013 Nov 4.
8
A study of [3H]aldosterone binding by nuclear and cytoplasmic receptors of the rat kidney with different content of aldosterone in the organism.
J Steroid Biochem. 1985 Sep;23(3):333-8. doi: 10.1016/0022-4731(85)90413-3.
9
Regulation of Na+ reabsorption in aldosterone target epithelia.
Kidney Blood Press Res. 1997;20(3):148-50. doi: 10.1159/000174128.
10
Possible interaction of anti-diuretic and sodium-retaining hormones in the kidney.
Nature. 1956 Nov 17;178(4542):1123. doi: 10.1038/1781123a0.

引用本文的文献

1
Aldosterone Breakthrough for the Prediction of Treatment Response to Mineralocorticoid Receptor Antagonists.醛固酮突破用于预测盐皮质激素受体拮抗剂的治疗反应
Kidney Med. 2025 May 30;7(8):101040. doi: 10.1016/j.xkme.2025.101040. eCollection 2025 Aug.
2
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.洛伦德司他用于未控制高血压和顽固性高血压患者：Launch-HTN随机临床试验
JAMA. 2025 Jun 30. doi: 10.1001/jama.2025.9413.
3
Emerging Pharmacological Approaches for the Treatment of Arterial Hypertension.

本文引用的文献

1
Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism.维生素 D 对慢性肾脏病的可能肾脏保护作用：超越矿物质代谢。
Nat Rev Nephrol. 2009 Dec;5(12):691-700. doi: 10.1038/nrneph.2009.185. Epub 2009 Oct 27.
2
The incidence and implications of aldosterone breakthrough.醛固酮突破的发生率及影响
Nat Clin Pract Nephrol. 2007 Sep;3(9):486-92. doi: 10.1038/ncpneph0575.
3
Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.肾素/前肾素受体在血管紧张素II生成及细胞对肾素反应中的关键作用。
治疗动脉高血压的新兴药理学方法
Biomedicines. 2025 Mar 25;13(4):790. doi: 10.3390/biomedicines13040790.
4
Drug Development in Pediatric Chronic Kidney Disease: A Review of Promising Treatments, Old Challenges, and New Strategies.儿童慢性肾脏病的药物研发：对有前景的治疗方法、旧挑战及新策略的综述
Paediatr Drugs. 2025 May;27(3):283-291. doi: 10.1007/s40272-025-00684-8. Epub 2025 Feb 10.
5
Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease.醛固酮受体拮抗剂在非糖尿病慢性肾脏病和肾小球疾病中的潜在作用。
Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1499-1512. doi: 10.2215/CJN.0000000000000540. Epub 2024 Jul 22.
6
The mineralocorticoid receptor in diabetic kidney disease.糖尿病肾病中的盐皮质激素受体。
Am J Physiol Renal Physiol. 2024 Sep 1;327(3):F519-F531. doi: 10.1152/ajprenal.00135.2024. Epub 2024 Jul 18.
7
Exercise-Induced Fluid Retention, Cardiac Volume Overload, and Peripheral Edema in Ultra-Distance Cyclists.超长距离自行车运动员的运动诱导性液体潴留、心脏容量超负荷和外周水肿
Kidney Int Rep. 2023 Oct 31;9(1):152-161. doi: 10.1016/j.ekir.2023.10.025. eCollection 2024 Jan.
8
The renin angiotensin aldosterone system.肾素-血管紧张素-醛固酮系统
Pflugers Arch. 2024 May;476(5):705-713. doi: 10.1007/s00424-024-02908-1. Epub 2024 Jan 17.
9
Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus.盐皮质激素受体拮抗剂在治疗2型糖尿病相关慢性肾脏病中的进展
Mayo Clin Proc Innov Qual Outcomes. 2022 Oct 15;6(6):536-551. doi: 10.1016/j.mayocpiqo.2022.09.002. eCollection 2022 Dec.
10
Aldosterone breakthrough from a pharmacological perspective.从药理学角度看醛固酮突破
Hypertens Res. 2022 Jun;45(6):967-975. doi: 10.1038/s41440-022-00913-4. Epub 2022 Apr 14.
J Clin Invest. 2002 Jun;109(11):1417-27. doi: 10.1172/JCI14276.